- News Home
27 November 2013 12:59 pm ,
Vol. 342 ,
Science has exposed a thriving academic black market in China involving shady agencies, corrupt scientists, and...
Paper-selling agencies flourish in the aura of reputable businesses. For some scientists, it may be difficult to tell...
The new head of the National Center for Science Education promises to "fight the good fight" against attacks on...
Analyses of the H7N9 strains isolated from four new cases show that the virus is evolving rapidly, heightening anxiety...
In 2009, Jack Szostak shared a Nobel Prize for his part in discovering the role of telomeres, the end bits of...
Featuring the first lunar rover in 40 years, Chang'e-3 is seen as an important milestone on China's quest to send a...
Data collected by satellites and floating probes have chronicled a 2-decade rise in the temperature and thickness of a...
Cholesterol, the artery-clogging molecule that contributes to cardiovascular disease, has another nasty trick up its...
- 27 November 2013 12:59 pm , Vol. 342 , #6162
- About Us
Nobelists Lobby Bush on Stem Cells
22 February 2001 7:00 pm
Eighty Nobel Prize winners have signed a letter urging President Bush to allow work on human pluripotent stem cells to go forward. In a letter faxed to the White House this morning, they argue that the cells--which have the capacity to develop into any tissue type--could help treat a variety of diseases. The Bush Administration is under pressure from antiabortion groups to block funding for work on the cells.
Teams around the world are working on strategies to prompt stem cells to replace dead cells in diseases like Parkinson's or diabetes. Some of this research is on cells derived from aborted fetuses or days-old human embryos. Opponents of such research argue that some studies have shown that stem cells from adults could produce the same results without the ethical problems. But the Nobel laureates' letter calls this assertion "premature." Stem cells from adults may prove very useful, says signatory Paul Berg, a biochemist at Stanford University, but "we can't ignore the potential of embryonic stem cells. ... We should be proceeding full-speed along both tracks."
Shortly after his inauguration, Bush ordered a review of the current National Institutes of Health (NIH) policy, which allows the funding of embryonic stem cell studies as long as researchers receive the cells from privately funded researchers who have derived them in accord with a set of ethical guidelines (ScienceNOW, 23 August 2000). (For example, applicants must certify that the cells were derived from embryos that were created for fertility treatments but were slated to be discarded because they were no longer needed.) The next deadline for submitting applications for such work is 15 March, and, barring a change in policy, applications will be reviewed by an ethics board in April.
The letter was written and circulated by researchers Robert Lanza and Michael West of Advanced Cell Technology, a biotechnology company in Worcester, Massachusetts. The duo, with many of the same laureates, signed a similar letter in 1999 urging Harold Varmus, then NIH director, to go forward with a plan to fund work on the cells (Science, 19 March 1999, p. 1849). That letter was "successful," says Lanza, who hopes the current letter will show the president that "the scientific community is unified in support of this research."